Literature DB >> 17373842

HDM2-binding partners: interaction with translation elongation factor EF1alpha.

Rebecca Frum1, Scott A Busby, Mahesh Ramamoorthy, Sumitra Deb, Jeffrey Shabanowitz, Donald F Hunt, Swati P Deb.   

Abstract

To understand the cellular functions of HDM2, we attempted to identify novel HDM2-interacting proteins by proteomic analysis. Along with previously identified interactions with the ribosomal proteins, our analysis reveals interactions of HDM2 with the ribosomal translation elongation factor EF1alpha, 40S ribosomal protein S20, tubulins, glyceraldehyde 3-phosphate dehydrogenase, and a proteolysis-inducing factor dermicidin in the absence of tumor suppressor p53. Because a CTCL tumor antigen HD-CL-08 has high degree of homology with EF1alpha, we confirmed interaction of HDM2 with EF1alpha by immunoprecipitation and Western blot analysis in transformed as well as near normal diploid cells. Endogenous HDM2- EF1alpha complex was detected in cancer cells overexpressing HDM2, suggesting a possible role of this interaction in HDM2-mediated oncogenesis. Consistent with their interaction, colocalization of HDM2 and EF1alpha can be detected in the cytoplasm of normal or transformed cells. Amino acid residues 1-58 and 221-325 of HDM2 were found to be essential for its interaction with EF1alpha, suggesting that the interaction is independent of its other ribosomal interacting proteins L5, L11, and L23. Overexpression of HDM2 did not affect translation. Because EF1alpha has been implicated in DNA replication and severing of microtubules, interaction of HDM2 with EF1alpha may signify a p53-independent cell growth regulatory role of HDM2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373842      PMCID: PMC4626875          DOI: 10.1021/pr060584p

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  39 in total

Review 1.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

2.  Regulation of HDM2 activity by the ribosomal protein L11.

Authors:  Marion A E Lohrum; Robert L Ludwig; Michael H G Kubbutat; Mary Hanlon; Karen H Vousden
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

Review 3.  MDM2 function.

Authors:  G Lozano; R Montes de Oca Luna
Journal:  Biochim Biophys Acta       Date:  1998-04-17

4.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

5.  Subfemtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI fourier transform ion cyclotron resonance mass spectrometry.

Authors:  S E Martin; J Shabanowitz; D F Hunt; J A Marto
Journal:  Anal Chem       Date:  2000-09-15       Impact factor: 6.986

6.  Inhibition of HDM2 and activation of p53 by ribosomal protein L23.

Authors:  Aiwen Jin; Koji Itahana; Kevin O'Keefe; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

7.  Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

Authors:  R Honda; H Yasuda
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

Review 8.  MDM2 and prognosis.

Authors:  Kenan Onel; Carlos Cordon-Cardo
Journal:  Mol Cancer Res       Date:  2004-01       Impact factor: 5.852

Review 9.  p53-independent functions of MDM2.

Authors:  Gitali Ganguli; Bohdan Wasylyk
Journal:  Mol Cancer Res       Date:  2003-12       Impact factor: 5.852

10.  MDM2 negatively regulates the human telomerase RNA gene promoter.

Authors:  Jiangqin Zhao; Alan Bilsland; Katrina Jackson; W Nicol Keith
Journal:  BMC Cancer       Date:  2005-01-18       Impact factor: 4.430

View more
  11 in total

1.  Human Oncoprotein MDM2 Up-regulates Expression of NF-κB2 Precursor p100 Conferring a Survival Advantage to Lung Cells.

Authors:  Catherine Vaughan; Lathika Mohanraj; Shilpa Singh; Catherine I Dumur; Mahesh Ramamoorthy; Carleton T Garrett; Brad Windle; W Andrew Yeudall; Sumitra Deb; Swati Palit Deb
Journal:  Genes Cancer       Date:  2011-10

2.  Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells.

Authors:  S Singh; M Ramamoorthy; C Vaughan; W A Yeudall; S Deb; S Palit Deb
Journal:  Cell Death Differ       Date:  2012-12-14       Impact factor: 15.828

3.  FMRP-dependent Mdm2 dephosphorylation is required for MEF2-induced synapse elimination.

Authors:  Nien-Pei Tsai; Julia R Wilkerson; Weirui Guo; Kimberly M Huber
Journal:  Hum Mol Genet       Date:  2017-01-15       Impact factor: 6.150

4.  Therapeutic considerations for Mdm2: not just a one trick pony.

Authors:  Jason A Lehman; Jacob A Eitel; Christopher N Batuello; Lindsey D Mayo
Journal:  Expert Opin Drug Discov       Date:  2008-11       Impact factor: 6.098

5.  Loss of fragile X protein FMRP impairs homeostatic synaptic downscaling through tumor suppressor p53 and ubiquitin E3 ligase Nedd4-2.

Authors:  Kwan Young Lee; Kathryn A Jewett; Hee Jung Chung; Nien-Pei Tsai
Journal:  Hum Mol Genet       Date:  2018-08-15       Impact factor: 6.150

6.  Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95.

Authors:  Nien-Pei Tsai; Julia R Wilkerson; Weirui Guo; Marina A Maksimova; George N DeMartino; Christopher W Cowan; Kimberly M Huber
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

7.  Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity.

Authors:  Alvaro Blanch; Fiona Robinson; Ian R Watson; Lynn S Cheng; Meredith S Irwin
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

8.  Interplay between human nucleolar GNL1 and RPS20 is critical to modulate cell proliferation.

Authors:  Rehna Krishnan; Neelima Boddapati; Sundarasamy Mahalingam
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

9.  Microarray-based cancer prediction using soft computing approach.

Authors:  Xiaosheng Wang; Osamu Gotoh
Journal:  Cancer Inform       Date:  2009-05-26

Review 10.  Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability.

Authors:  Tae-Hyung Kim; Patrick Leslie; Yanping Zhang
Journal:  Oncotarget       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.